1. Β-Blockers and retroperitoneal fibrosis

   Newsletter Article 10 February 2013 Pages: 2 - 2

2. The safety of aspartame

   Newsletter Article 10 February 2013 Pages: 2 - 2

3. Acute respiratory distress in an infant who swallowed a sterilising tablet

   Newsletter Article 10 February 2013 Pages: 2 - 2

4. The adverse effects of Β-blockers on renal function

   Newsletter Article 10 February 2013 Pages: 2 - 3

5. The safety of co-trimoxazole

   Newsletter Article 10 February 2013 Pages: 3 - 3

6. Drug-induced fibrotic reactions

   Newsletter Article 10 February 2013 Pages: 3 - 3

7. Adverse effects associated with the administration of antibacterials during pregnancy

   Newsletter Article 10 February 2013 Pages: 3 - 4

8. Adverse effects associated with imipenem/cilastatin

   Newsletter Article 10 February 2013 Pages: 4 - 4

9. Amiodarone*

   Newsletter Article 10 February 2013 Pages: 4 - 5

10. Anti-inflammatories, non-steroidal

    Newsletter Article 10 February 2013 Pages: 5 - 5

11. Β-Blockers +; diuretics

    Newsletter Article 10 February 2013 Pages: 5 - 5

12. Carbamazepine

    Newsletter Article 10 February 2013 Pages: 5 - 5

13. Cefamandole/cefapirin

    Newsletter Article 10 February 2013 Pages: 5 - 5

14. Cefapirin see Cefamandole

    Newsletter Article 10 February 2013 Pages: 5 - 5

15. Cimetidine

    Newsletter Article 10 February 2013 Pages: 6 - 6

16. Cyclosporin

    Newsletter Article 10 February 2013 Pages: 6 - 6

17. Dicloxacillin

    Newsletter Article 10 February 2013 Pages: 6 - 6

18. Dicloxacillin see Flucloxacillin

    Newsletter Article 10 February 2013 Pages: 6 - 6

19. Diuretics see Β-Blockers

    Newsletter Article 10 February 2013 Pages: 6 - 6

20. Domperidone

    Newsletter Article 10 February 2013 Pages: 6 - 6

21. Domperidone overdose

    Newsletter Article 10 February 2013 Pages: 6 - 6

22. Enalapril

    Newsletter Article 10 February 2013 Pages: 6 - 6

23. Flucloxacillin

    Newsletter Article 10 February 2013 Pages: 6 - 6

24. Flucloxacillin/dicloxacillin

    Newsletter Article 10 February 2013 Pages: 6 - 7

25. Griseofulvin

    Newsletter Article 10 February 2013 Pages: 7 - 7

26. Hydrochlorothiazide

    Newsletter Article 10 February 2013 Pages: 7 - 7

27. Hydrochlorothiazide see Triamterene

    Newsletter Article 10 February 2013 Pages: 7 - 7

28. Imipramine

    Newsletter Article 10 February 2013 Pages: 7 - 7

29. Isoniazid

    Newsletter Article 10 February 2013 Pages: 7 - 8

30. Latamoxef

    Newsletter Article 10 February 2013 Pages: 8 - 8

31. Lithium interaction see Piroxicam

    Newsletter Article 10 February 2013 Pages: 8 - 8

32. Mefenamic acid overdose

    Newsletter Article 10 February 2013 Pages: 8 - 8

33. Nomifensine

    Newsletter Article 10 February 2013 Pages: 8 - 9

34. Paracetamol overdose

    Newsletter Article 10 February 2013 Pages: 9 - 9

35. Phenacetin

    Newsletter Article 10 February 2013 Pages: 9 - 9

36. Piroxicam interaction

    Newsletter Article 10 February 2013 Pages: 9 - 9

37. Propranolol

    Newsletter Article 10 February 2013 Pages: 9 - 9

38. Rifampicin

    Newsletter Article 10 February 2013 Pages: 9 - 9

39. Rifampicin interaction see Verapamil interaction

    Newsletter Article 10 February 2013 Pages: 9 - 9

40. Salicylates

    Newsletter Article 10 February 2013 Pages: 9 - 10

41. Tolazamide

    Newsletter Article 10 February 2013 Pages: 10 - 10

42. Trazodone

    Newsletter Article 10 February 2013 Pages: 10 - 10

43. Triamterene +; hydrochlorothiazide

    Newsletter Article 10 February 2013 Pages: 10 - 10

44. Vancomycin*

    Newsletter Article 10 February 2013 Pages: 10 - 10

45. Verapamil interaction

    Newsletter Article 10 February 2013 Pages: 10 - 10

46. Vincristine

    Newsletter Article 10 February 2013 Pages: 10 - 11

47. Drug-induced photosensitivity disorders

    Newsletter Article 10 February 2013 Pages: 11 - 12

48. Drug-induced erythema multiforme (continued)

    Newsletter Article 10 February 2013 Pages: 12 - 12